Provided By GlobeNewswire
Last update: Apr 2, 2025
Raanana, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally recognized branding and trademark consultancy firm, renowned for working with leading pharmaceutical and medical device companies worldwide.
Read more at globenewswire.comNASDAQ:PLRZ (4/21/2025, 4:30:01 PM)
0.33
-0.03 (-7.28%)
Find more stocks in the Stock Screener